相关实验视频

Updated: Jul 27, 2025

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

Published on: June 26, 2018

脊髓损伤和处方阿片类药物治疗疼痛:一个范围审查

Jo Ann Shoup^1,2, JoEllen Welter^3,4, Ingrid A Binswanger^1,5,6,7

¹Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO 80014, United States.

Pain medicine (Malden, Mass.)

|June 6, 2023

概括

脊髓损伤 (SCI) 患者经常使用处方阿片类药物治疗疼痛. 在了解阿片类药物使用方面存在研究差距,特别是在SCI人群中的不同人口结构和风险因素方面.

科学领域:

神经学神经学
疼痛管理疼痛管理
公共卫生公共卫生

背景情况:

脊髓损伤 (SCI) 显著影响身体和心理社会福祉,往往导致慢性疼痛.
患有SCI的人因持续疼痛而更有可能接触处方阿片类药物.
了解处方阿片类药物使用模式和SCI的风险因素对于有效的疼痛管理和患者安全至关重要.

研究的目的:

对已发表的关于急性脊髓损伤后和处方阿片类药物治疗疼痛的研究进行范围审查.
综合有关阿片类药物使用的发现,确定现有的文献差距,并提出未来的研究方向.

主要方法:

在六个主要的电子文献数据库 (PubMed,MEDLINE,EMBASE,Cochrane图书馆,CINAHL,PsychNET) 搜索了从2014年到2021年的文章.
包括英语的同行评审文章,重点关注脊髓损伤和处方阿片类药物的使用.
提取了关于阿片类药物使用的数据,确定了风险因素,并进行了差距分析.

主要成果:

包括16篇文章,其中大多数研究来源于美国.
在报告人口统计数据方面发现了显著的差距,包括收入 (87.5%),种族 (87.5%) 和种族 (75%).
处方阿片类药物的使用率从35%到64%不等. 确定的危险因素包括中年,低收入,骨关节炎,先前使用阿片类药物和较低水平的SCI.

结论:

未来的研究必须报告关于SCI人群处方阿片类药物使用的全面数据.
包括人口统计数据 (种族,种族,收入) 对于理解风险结果至关重要.
解决报告多样性和方法学的差距将提高SCI疼痛管理的证据质量.

关键词:

疼痛疼痛疼痛疼痛处方阿片类药物可以使用.脊髓损伤导致的脊髓损伤

更多相关视频

Acute and Chronic Tactile Sensory Testing after Spinal Cord Injury in Rats

Acute and Chronic Tactile Sensory Testing after Spinal Cord Injury in Rats

Published on: April 4, 2012

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...